Scarica l'app Stockscreener
52.62
1.27%
0.66
Dopo l'orario di chiusura:
52.65
0.03
+0.06%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$51.96
Aprire:
$52.23
Volume 24 ore:
13.08M
Relative Volume:
1.01
Capitalizzazione di mercato:
$62.83B
Reddito:
$368.91B
Utile/perdita netta:
$5.02B
Rapporto P/E:
13.36
EPS:
3.94
Flusso di cassa netto:
$1.69B
1 W Prestazione:
+9.60%
1M Prestazione:
+19.48%
6M Prestazione:
-14.58%
1 anno Prestazione:
-31.65%
Intervallo 1D:
$51.80
$52.89
Intervallo di 1 settimana:
$49.52
$52.89
Portata 52W:
$43.56
$80.75
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Confronta CVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
52.62 | 62.83B | 368.91B | 5.02B | 1.69B | 3.94 |
|
UNH
Unitedhealth Group Inc
|
509.76 | 469.12B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
385.29 | 89.36B | 174.02B | 6.42B | 871.00M | 27.43 |
|
CI
Cigna Group
|
283.99 | 78.99B | 229.75B | 3.04B | 5.18B | 10.60 |
|
HUM
Humana Inc
|
282.63 | 34.03B | 115.01B | 1.36B | -4.34B | 11.29 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
Polianta Ltd Grows Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Sold by Trust Co. of Vermont - MarketBeat
CVS Health Co. (NYSE:CVS) Stake Lowered by Albert D Mason Inc. - MarketBeat
CVS Health: One Ugly Chart, Leverage Issues, Trump Problems, Recession/Competition Risks (NYSE:CVS) - Seeking Alpha
Avanza Fonder AB Makes New $4.75 Million Investment in CVS Health Co. (NYSE:CVS) - MarketBeat
Empirical Asset Management LLC Buys 32,860 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
CVS (CVS Health) Forward Dividend Yield % : 5.06% (As of Jan. 19, 2025) - GuruFocus.com
CVS Health Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Is CVS Health (CVS) the Best Fortune 500 Dividend Stock to Buy Right Now? - Insider Monkey
CVS Health (NYSE:CVS) Stock Price Up 1.1%Time to Buy? - MarketBeat
Dividend Roundup: Citigroup, Procter & Gamble, Caterpillar, CVS Health, and more - Seeking Alpha
CVS Health Co. (NYSE:CVS) Stock Holdings Decreased by Gateway Investment Advisers LLC - MarketBeat
Assenagon Asset Management S.A. Lowers Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health (NYSE:CVS) Stock Price Down 0.6%Time to Sell? - MarketBeat
CVS Health Isn't Going To The Dogs - Seeking Alpha
CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Insurance, Pharmacy Benefit Manager Company Stocks Drop Following UnitedHealth's Q4 Revenue Miss: What's Going On? - Benzinga
CVS Health (NYSE:CVS) Stock Price Down 1.7%Here's Why - MarketBeat
FTC to bring lawsuit against CVS, Cigna, and UnitedHealth Group - The American Bazaar
Several Setbacks Dragged CVS Health Corp. (CVS) in Q4 - Insider Monkey
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know - MSN
Oak Thistle LLC Invests $837,000 in CVS Health Co. (NYSE:CVS) - MarketBeat
Claro Advisors LLC Decreases Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Corp. stock rises Wednesday, still underperforms market - MarketWatch
Is CVS Health (CVS) the Hottest Large-Cap Stock So Far in 2025? - Insider Monkey
Healthcare: Sector Looks Undervalued with Pullback After US Election and Obesity Data - Morningstar
CVS Health (NYSE:CVS) Trading Up 1.1%Still a Buy? - MarketBeat
Why UnitedHealth and CVS Are Set to Dominate the $21 Billion Medicare Advantage Surge - Yahoo Canada Finance
CVS Health Corp (CVS)'s Uncertain Future: Understanding the Barriers to Outperformance - GuruFocus.com
CVS stock retains Overweight rating on expected developments - Investing.com
Meyer Handelman Co. Sells 9,103 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Radnor Capital Management LLC Sells 12,479 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
3 Dividend Stocks at Bargain Levels to Defend Your Portfolio - MarketBeat
CVS Health: Current Price Offers Favorable Risk-Reward Profile - Yahoo Finance
Can Integrated Healthcare Stocks Succeed in Public Markets? - Benzinga
CVS CEO Exit Ends Promising Era of Women Heading Pharmacy Chains - MSN
FTC accuses CVS, Cigna, UnitedHealth of abusing middleman role, shares down - MSN
CVS Accused of Illegal Opioid Dispensing in Federal Suit - MSN
What You Need To Know Ahead of CVS Health's Earnings Release - Nasdaq
CVS Health Corp. stock rises Tuesday, still underperforms market - MarketWatch
Do Dr. Oz's Health Care Stocks Create a Conflict of Interest? - MSN
FTC Says CVS, Cigna and UnitedHealth Abuse Middleman Role - Bloomberg
FTC Says CVS, Cigna and UnitedHealth Abuse Middleman Role (3) - Bloomberg Law
FTC says CVS, Cigna, and UnitedHealth abuse middleman role - The Boston Globe
US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain - Yahoo News Canada
FTC Accuses CVS, Cigna, UnitedHealth of Abusing Middleman Role - Bloomberg Law
Why CVS Health (CVS) Led the Monday Upsurge? - MSN
What You Need To Know Ahead Of CVS Health's Earnings Release - Barchart
Oak Asset Management LLC Has $2.48 Million Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Position Reduced by Peddock Capital Advisors LLC - MarketBeat
CVS Health (NYSE:CVS) Stock Price Up 6.3%Time to Buy? - MarketBeat
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.07%
0.99%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):